CJC-1295 No DAC

A$99.00

CJC-1295 No DAC, a GHRH analogue studied in pituitary growth hormone release.

Research use only. Not for human or veterinary use.

In stock

All prices are in AUD. Ships from Australia with tracked express shipping, $15 flat, 1 to 2 business days, free on orders over $200. Research use only, not for human or veterinary use.

  • Testing status on this page
  • Same-day dispatch before 2pm
  • Dispatched from Australia
  • Card, Apple Pay & Google Pay

Research use only

Not for human or veterinary use.

Laboratory chemical

Supplied for in vitro research. We publish specifications and handling guidance only, with no protocols and no advice on use.

Not on the ARTG

Absent from the Australian Register of Therapeutic Goods and never evaluated by the TGA for safety, quality or efficacy. Absence from the register is not an approval and does not authorise any other use.

Who can order

You must be 18 or over and purchasing solely for lawful research.

What is CJC-1295 No DAC?

CJC-1295 without DAC, also sold as Mod GRF 1-29, is a tetra-substituted analogue of GHRH (1-29) modified for improved stability in solution. It is used in pituitary somatotroph culture to study receptor activation and pulsatile growth hormone release, and NuVion stocks it in Australia as a 10mg lyophilised vial.

  • Tetra-substituted GHRH (1-29) analogue, also called Mod GRF 1-29
  • Used in pituitary somatotroph culture models
  • Applied in cAMP accumulation and receptor activation assays
  • Supplied lyophilised, purity by RP-HPLC and identity by mass spectrometry

CJC-1295 No DAC structure and research use

CJC-1295 No DAC is the first 29 amino acids of GHRH with four substitutions that protect the chain from enzymatic cleavage and oxidation. It acts at the GHRH receptor on pituitary somatotrophs and signals through cyclic AMP. Ghrelin receptor agonists such as ipamorelin act at a different receptor on the same cells, which is why the two classes are compared in somatotroph work.

CJC-1295 No DAC research applications

  • cAMP accumulation in cultured pituitary somatotrophs, measured against unmodified GRF(1-29) as the comparator peptide
  • Enzyme assays with dipeptidyl peptidase 4, measuring how the D-Ala2 substitution protects the N-terminal dipeptide
  • Binding and selectivity panels comparing the GHRH receptor with class B1 receptors for secretin, VIP and glucagon
  • Somatotroph readouts of CREB phosphorylation by western blot and growth hormone in the medium by ELISA

CJC-1295 No DAC key facts

Type Synthetic GHRH analogue, the form without the drug affinity complex (DAC)
Amino acid count 29
Substitutions D-Ala2, Gln8, Ala15, Leu27 on GRF(1-29)
Also known as Modified GRF 1-29, Mod GRF (1-29)
Vial size 10mg, lyophilised
Purity 99.46% by RP-HPLC, Janoshik Analytical
Analysed 9 July 2026

Independent test: a sample of this product was analysed by Janoshik Analytical on 9 July 2026, purity 99.46% by RP-HPLC, test number 195039. The full report opens from the lab band on this page.

Why buy CJC-1295 No DAC from NuVion

Testing status on every page

Published results show the measured purity, the date and the certificate.

Australian stock, domestic post

Held in Australia and sent tracked in plain outer packaging.

Specifications

CAS Number 446262-90-4
Molecular Weight 3367.9
Molecular Formula C152H252N44O42

Storing and handling CJC-1295 No DAC

Before reconstitution
Keep the sealed vial cool, dry and out of direct light. General practice for lyophilised peptides.
After reconstitution
Reconstitute with bacteriostatic or sterile water, store at 2 to 8°C and avoid repeated freeze-thaw cycles. No stability-tested shelf life is published for this product.

Reconstitution and storage Volumes, concentrations and storage at a glance.

CJC-1295 No DAC questions

Where can I buy CJC-1295 in Australia?
NuVion stocks CJC-1295 in Australia as a 10mg vial of lyophilised powder, posted from Australian stock on a tracked express service. A sample was analysed by Janoshik Analytical on 9 July 2026, with purity of 99.46% by RP-HPLC. It also comes in the Metabolic Signalling Set, the Somatotropic Axis Set, the Metabolic Signalling Set (Extended) and the GHRH & Secretagogue Pair. Bacteriostatic water is sold separately. CJC-1295 is supplied as a research material only and is not on the Australian Register of Therapeutic Goods.
How does CJC-1295 No DAC work at the cell level?
CJC-1295 No DAC binds the growth hormone releasing hormone receptor, a class B1 G protein-coupled receptor expressed on pituitary somatotrophs. The receptor couples to Gs, which raises adenylyl cyclase activity and intracellular cyclic AMP. The CJC-1295 No DAC research profile covers the mechanism in full.
Which four substitutions does CJC-1295 No DAC carry, and why?
CJC-1295 No DAC carries D-Ala2, Gln8, Ala15 and Leu27 on GRF(1-29). D-alanine blocks cleavage by dipeptidyl peptidase 4, glutamine removes an asparagine prone to deamidation, alanine sits in place of a glycine, and leucine replaces a methionine that would oxidise.
What molecular mass identifies CJC-1295 No DAC?
CJC-1295 No DAC has a molecular mass near 3368 g/mol. A figure near 3647 g/mol belongs to the 30-residue form with DAC, which is a different molecule from this product. Residue count and mass are the reliable way to separate the two.
What parent sequence is CJC-1295 No DAC built on?
CJC-1295 No DAC is built on GRF(1-29), the first twenty-nine residues of growth hormone releasing hormone. That fragment is the shortest one that retains full activity at the receptor. Sermorelin is the unmodified GRF(1-29) amide.
Is CJC-1295 No DAC the same as Mod GRF 1-29?
Yes. Mod GRF 1-29, short for modified growth hormone releasing factor 1-29, is another name for CJC-1295 without DAC. Both names describe the same 29 amino acid analogue.
What is the difference between CJC-1295 with DAC and without DAC?
DAC is a chemical group added to the peptide so that it binds albumin. The No DAC form is the same 29 amino acid analogue without that group. This product is the No DAC form.
How is CJC-1295 different from ipamorelin?
They act at different receptors. CJC-1295 is a GHRH analogue and acts at the GHRH receptor. Ipamorelin is a pentapeptide agonist at the ghrelin receptor GHS-R1a. NuVion stocks both separately, and together in the CJC-1295 No DAC / Ipamorelin Blend.

Shipping, returns and wholesale orders are covered in the FAQs.

Related research peptides

NuVion Sermorelin research peptide vial
5mg

Original price was: A$79.00.Current price is: A$69.00.

NuVion KPV research peptide vial

KPV

10mg

A$69.00

NuVion KLOW research peptide blend vial
80mg

A$179.00

NuVion GHRP-2 research peptide vial
10mg

Original price was: A$79.00.Current price is: A$69.00.